High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3

Background Primary macronodular adrenal hyperplasia (PMAH) is a rare cause of Cushing’s syndrome, characterized by functioning adrenal macronodules and variable cortisol production. Recently, we demonstrated a high 18F-FDG uptake in PMAH, an unexpected finding for a benign disorder. Purpose To investigate whether there is a correlation between 18F-FDG high uptake and the expression levels of the glycolytic pathway components GLUT1, HK1, HK2, and HK3 in PMAH. Material and Methods We selected 12 patients undergoing surgery for PMAH who had preoperatively undergone 18F-FDG PET/CT. mRNA and protein expression of the selected genes were evaluated in the adrenal nodules from patients who underwent surgery through quantitative RT-PCR and by immunohistochemistry, respectively. Results SUVmax in PMAH was in the range of 3.3–8.9 and the adrenal size was in the range of 3.5–15 cm. A strong correlation between 18F-FDG uptake and largest adrenal diameter was observed in patients with PMAH. However, no correlation between 18F-FDG uptake and GLUT1, HK1, HK2, HK3 mRNA, and protein expression was observed. Conclusion High 18F-FDG uptake is observed in the majority of PMAH cases. However, 18F-FDG uptake in PMAH is independent of the expression levels of GLUT1, HK1, HK2, and HK3. Further investigation is required to elucidate the molecular mechanisms underlying increased 18F-FDG uptake in PMAH.

[1]  Eric J. W. Visser,et al.  Correlation Between In Vivo 18F-FDG PET and Immunohistochemical Markers of Glucose Uptake and Metabolism in Pheochromocytoma and Paraganglioma , 2014, The Journal of Nuclear Medicine.

[2]  Yuka Yamamoto,et al.  Molecular Mechanism Underlying the Detection of Colorectal Cancer by 18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography , 2012, Journal of Gastrointestinal Surgery.

[3]  A. Lerário,et al.  (18)F-FDG-PET/CT imaging of ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) demonstrating increased (18)F-FDG uptake. , 2011, The Journal of clinical endocrinology and metabolism.

[4]  R. Dudczak,et al.  PET and PET/CT in endocrine tumours. , 2010, European journal of radiology.

[5]  A. Kjaer,et al.  F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors , 2010 .

[6]  H. Müller-Hermelink,et al.  Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma. , 2009, Endocrine-related cancer.

[7]  N. Holalkere,et al.  PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. , 2009, AJR. American journal of roentgenology.

[8]  A. Lacroix.  ACTH-independent macronodular adrenal hyperplasia. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[9]  P. Chow,et al.  2-[18f]-2-deoxy-d-glucose (fdg) uptake in human tumor cells is related to the expression of glut-1 and hexokinase ii , 2008, Acta radiologica.

[10]  L. Nieman,et al.  Cushing's syndrome , 2005 .

[11]  I. Brink,et al.  Factors Influencing [F‐18] 2‐Fluoro‐2‐Deoxy‐d‐Glucose (F‐18 FDG) Uptake in Melanoma Cells: The Role of Proliferation Rate, Viability, Glucose Transporter Expression and Hexokinase Activity , 2005, The Journal of dermatology.

[12]  T. Manabe,et al.  [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. , 2005, Neoplasia.

[13]  S. Antonini,et al.  [Clinical and molecular aspects of the ACTH-independent bilateral macronodular adrenal hyperplasia]. , 2004, Arquivos brasileiros de endocrinologia e metabologia.

[14]  Y. Tsushima,et al.  High [18F] 2-fluoro-2-deoxy-d-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome , 2003, Annals of nuclear medicine.

[15]  E. Lin,et al.  Adrenal hyperplasia in Cushing's syndrome demonstrated by FDG positron emission tomographic imaging. , 2002, Clinical nuclear medicine.

[16]  C. Stratakis,et al.  Cyclic AMP‐Dependent Signaling Aberrations in Macronodular Adrenal Disease , 2002, Annals of the New York Academy of Sciences.

[17]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[18]  R L Wahl,et al.  Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  G. van Kaick,et al.  FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. , 1994, Nuclear medicine and biology.

[20]  E B Cox,et al.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. , 1985, Archives of pathology & laboratory medicine.

[21]  R. Powell,et al.  CUSHING'S SYNDROME: NODULAR CORTICAL HYPERPLASIA OF ADRENAL GLANDS WITH CLINICAL AND PATHOLOGICAL FEATURES SUGGESTING ADRENOCORTICAL TUMOR. , 1964, The Journal of clinical endocrinology and metabolism.

[22]  H. Cushing.  The Basophil Adenomas of the Pituitary Body and Their Clinical Manifestations (Pituitary Basophilism) , 1964 .

[23]  U. Metser,et al.  18F-FDG PET/CT in the evaluation of adrenal masses. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  T. Yen,et al.  18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.